Last $119.25 USD
Change Today -0.38 / -0.32%
Volume 362.8K
HSIC On Other Exchanges
Symbol
Exchange
Munich
As of 8:10 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

henry schein inc (HSIC) Snapshot

Open
$119.90
Previous Close
$119.63
Day High
$119.90
Day Low
$119.06
52 Week High
04/4/14 - $120.99
52 Week Low
09/3/13 - $100.64
Market Cap
10.1B
Average Volume 10 Days
336.1K
EPS TTM
$5.33
Shares Outstanding
84.8M
EX-Date
--
P/E TM
22.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for HENRY SCHEIN INC (HSIC)

Related News

No related news articles were found.

henry schein inc (HSIC) Related Businessweek News

View More BusinessWeek News

henry schein inc (HSIC) Details

Henry Schein, Inc. distributes health care products and services worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, such as infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, equipment repair, and high-tech equipment. This segment also provides animal health products consisting of branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products, comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services and products, including practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions comprising financial services on a non-recourse basis, e-services, and continuing education services for practitioners. The company primarily serves dental practitioners and laboratories, physician practices, and animal health clinics, as well as government, institutional health care clinics, and other alternate care clinics. Henry Schein, Inc. has a strategic alliance with Athenahealth, Inc. to facilitate uniform data system reporting, which is a requirement for CHCs, including federally qualified health centers. The company was founded in 1932 and is headquartered in Melville, New York.

henry schein inc (HSIC) Top Compensated Officers

Executive Chairman and Chief Executive Office...
Total Annual Compensation: $1.2M
President, Chief Operating Officer, Executive...
Total Annual Compensation: $744.2K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $587.2K
Chief Administrative Officer, Executive Vice ...
Total Annual Compensation: $557.2K
Senior Advisor
Total Annual Compensation: $507.2K
Compensation as of Fiscal Year 2013.

henry schein inc (HSIC) Key Developments

Henry Schein, Inc. Opens New Utah Headquarters

Henry Schein, Inc. announced the opening of a new headquarters building for its Practice Solutions business in American Fork, Utah, that will offer practitioners a training facility on digital dentistry. The 100,000-square-foot, environmentally friendly facility features a "Center of Excellence" equipped with high-quality digital dental equipment and technology from Henry Schein's valued supplier partners, including the Kavo Kerr Group, a Danaher company; Air Techniques; SciCan; and Planmeca, which provided its CAD CAM solutions. The new Center of Excellence will showcase innovative products to new dentists and provide local dental professionals a modern facility to offer free, high-quality oral care to the community's underserved population.

Nobel Biocare Said To Draw Interests

Nobel Biocare Holding AG (SWX:NOBN) ) that’s exploring a sale, has attracted interest from potential buyers including EQT Partners AB and Danaher Corp. (NYSE:DHR), said people with knowledge of the matter. Nobel Biocare was initially approached by EQT with an offer of about CHF 17 a share, which would have valued the company at about CHF 2.1 billion said the people, who asked not to be identified because talks are private. The offer prompted Nobel Biocare and its adviser Goldman Sachs Group Inc. (GS) to invite other bids as it seeks a higher price, the people said. Other companies such as DENTSPLY International Inc. (NasdaqGS:XRAY) and buyout firms are also expected to look at Nobel Biocare, the people said. Potential buyers include Straumann Holding AG (SWX:STMN), Sirona Dental Systems Inc., Johnson & Johnson (NYSE:JNJ), Medtronic, Inc. (NYSE:MDT), Zimmer Holdings, Inc. (NYSE:ZMH), Henry Schein, Inc. (NasdaqGS:HSIC), and 3M Company (NYSE:MMM), according to a note on July 30 from Lisa Bedell Clive, a London-based analyst at Sanford C. Bernstein & Co. Nobel Biocare could sell for as much as CHF 18 a share, she said in the note.

Henry Schein, Inc. Announces Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended June 28, 2014; Revised Earnings Guidance for the Full Year of 2014

Henry Schein, Inc. announced consolidated unaudited earnings results for the second quarter and six months ended June 28, 2014. For the quarter, the company reported net sales of $2,615,406,000 compared with $2,391,810,000 for the same period a year ago. Operating income was $180,844,000 compared with $176,065,000 for the same period a year ago. Income before taxes and equity in earnings of affiliates was $179,622,000 compared with $174,444,000 for the same period a year ago. Net income attributable to the company was $116,236,000 or $1.35 per diluted share compared with $108,430,000 or $1.23 per diluted share for the same period a year ago. Net cash provided by operating activities was $199,232,000 compared with $274,798,000 for the same period a year ago. Purchases of fixed assets was $19,492,000 compared with $10,072,000 for the same period a year ago. Non-GAAP net income attributable to the company was $116,236,000 or $1.35 per diluted share compared with $108,430,000 or $1.23 per diluted share for the same period a year ago. Net sales climbed 9.3%. The sales growth consisted of 7.9% growth in local currencies and 1.4% growth related to foreign-currency exchange. In local currencies, internally generated sales increased 4.3% and acquisition growth was 3.6%. For the six months, the company reported net sales of $5,045,565,000 compared with $4,685,321,000 for the same period a year ago. Operating income was $338,112,000 compared with $329,694,000 for the same period a year ago. Income before taxes and equity in earnings of affiliates was $338,667,000 compared with $318,181,000 for the same period a year ago. Net income attributable to the company was $218,335,000 or $2.53 per diluted share compared with $199,908,000 or $2.27 per diluted share for the same period a year ago. Net cash provided by operating activities was $143,983,000 compared with $236,751,000 for the same period a year ago. Purchases of fixed assets was $37,976,000 compared with $21,934,000 for the same period a year ago. Non-GAAP net income attributable to the company was $218,335,000 or $2.53 per diluted share compared with $202,587,000 or $2.30 per diluted share for the same period a year ago. The company revised earnings guidance for the full year of 2014. For 2014, the company expects diluted EPS attributable to the company to be $5.33 to $5.39. This represents growth of 8% to 9% compared with 2013 results excluding certain one-time items, and compares with previous guidance for 2014 diluted EPS to be $5.29 to $5.39.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSIC:US $119.25 USD -0.38

HSIC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HSIC.
View Industry Companies
 

Industry Analysis

HSIC

Industry Average

Valuation HSIC Industry Range
No financial data is available for HSIC.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENRY SCHEIN INC, please visit www.henryschein.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.